Lanean...
Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness
Pulmonary arterial hypertension (PAH) is commonly treated with pulmonary arteriolar vasodilator therapy. When a patient on PAH medication is admitted to intensive care, determining how to manage their medication during the critical illness is often complicated. There may be considerations related to...
Gorde:
| Argitaratua izan da: | Crit Care |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4331447/ https://ncbi.nlm.nih.gov/pubmed/25673176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-014-0523-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|